Gainers
- TransCode Therapeutics (NASDAQ:RNAZ) stock rose 55.5% to $0.73 during Wednesday’s regular session. As of 12:30 EST, TransCode Therapeutics’s stock is trading at a volume of 35.8 million, which is 1131.1% of its average full-day volume over the last 100 days. The company’s market cap stands at $9.4 million.
- Sera Prognostics (NASDAQ:SERA) shares rose 38.92% to $1.82. As of 12:30 EST, this security is trading at a volume of 42.0 million shares, making up 152111.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $56.4 million.
- Organovo Holdings (NASDAQ:ONVO) shares increased by 27.3% to $2.78. The current volume of 621.9K shares is 962.0% of Organovo Holdings’s average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $24.1 million. The company’s, Q3 earnings came out 4 days ago.
- Vallon Pharmaceuticals (NASDAQ:VLON) stock moved upwards by 26.19% to $0.82. Trading volume for Vallon Pharmaceuticals’s stock is 39.8 million as of 12:30 EST. This is 519.4% of its average full-day volume over the last 100 days. The company’s market cap stands at $11.0 million.
- Tenon Medical (NASDAQ:TNON) stock rose 24.24% to $1.23. Trading volume for this security as of 12:30 EST is 9.5 million, which is 24840.7% of its average full-day volume over the last 100 days. The company’s market cap stands at $13.8 million.
- Vapotherm (NYSE:VAPO) stock moved upwards by 18.27% to $1.1. The current volume of 686.3K shares is 99.8% of Vapotherm’s average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $31.3 million.
Losers
- GlycoMimetics (NASDAQ:GLYC) shares decreased by 55.6% to $1.8 during Wednesday’s regular session. The current volume of 9.1 million shares is 835.1% of GlycoMimetics’s average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $94.3 million.
- T2 Biosystems (NASDAQ:TTOO) shares decreased by 22.26% to $0.84. As of 12:30 EST, T2 Biosystems’s stock is trading at a volume of 3.1 million, which is 1171.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.1 million.
- Galera Therapeutics (NASDAQ:GRTX) shares decreased by 17.77% to $1.62. Trading volume for Galera Therapeutics’s stock is 2.0 million as of 12:30 EST. This is 1680.2% of its average full-day volume over the last 100 days. The company’s market cap stands at $46.1 million.
- Entrada Therapeutics (NASDAQ:TRDA) shares fell 16.04% to $10.94. As of 12:30 EST, this security is trading at a volume of 67.7K shares, making up 115.2% of its average full-day volume over the last 100 days. The company’s market cap stands at $361.2 million.
- NeuBase Therapeutics (NASDAQ:NBSE) shares decreased by 15.46% to $0.3. Trading volume for this security as of 12:30 EST is 442.1K, which is 125.6% of its average full-day volume over the last 100 days. The company’s market cap stands at $10.0 million. The company’s, Q1 earnings came out yesterday.
- Soligenix (NASDAQ:SNGX) stock fell 14.53% to $4.06. The current volume of 79.0K shares is 452.4% of Soligenix’s average full-day volume over the last 100 days (last updated at 12:30 EST). The company’s market cap stands at $11.7 million.
See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
